drugset / Trial / NCT01934569

Drug-Drug Interaction Study With PF-05089771

NCT01934569

Phase 1 Completed 17 enrolled Pfizer
NaSingle-groupOpen-labelBasic science

Summary

This study will test the potential for PF-05089771 to interact with a cocktail of drugs

Timeline

Start
2013-09
Primary completion
2013-11
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Caffeine Small molecule 100 mg
Subject Losartan Other / unclassified 25 mg
Subject Midazolam Small molecule 7.5 mg
Subject Omeprazole Other / unclassified 20 mg
Subject PF-05089771 Small molecule 450 mg
Subject Pravastatin Small molecule 10 mg

Indications

No indication recorded.